LMO2, LIM domain only 2, 4005

N. diseases: 83; N. variants: 3
Disease: B-Cell Lymphomas ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas 		0.030 Biomarker group BEFREE LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas. 28288039 2017
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas 		0.030 Biomarker group BEFREE LMO2 is a transcription regulator involved in human T-cell leukemia, including some occurring in X-SCID gene therapy trials, and in B-cell lymphomas and prostate cancer. 19487290 2009
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas 		0.030 AlteredExpression group LHGDN Immunohistologic analysis of over 1200 normal and neoplastic tissue and cell lines showed that LMO2 protein is expressed as a nuclear marker in normal germinal-center (GC) B cells and GC-derived B-cell lines and in a subset of GC-derived B-cell lymphomas. 17038524 2007